| Lisa Andreas, LCSW | |
|
702 N Blackhawk Ave Ste 104, Madison, WI 53705-3357 | |
| (608) 237-8890 | |
| (608) 237-8891 |
| Full Name | Lisa Andreas |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 702 N Blackhawk Ave Ste 104, Madison, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124619242 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 9188-123 (Wisconsin) | Secondary |
| 101YM0800X | Counselor - Mental Health | 9188-123 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Andreas, LCSW 6516 Monona Dr # 156, Monona, WI 53716-4026 Ph: (608) 237-8890 | Lisa Andreas, LCSW 702 N Blackhawk Ave Ste 104, Madison, WI 53705-3357 Ph: (608) 237-8890 |
News Archive
Receptos, a drug discovery and development company, announced today the establishment of a collaboration with Eli Lilly and Company to research and develop small molecule modulators of an undisclosed GPCR target.
NPR: The Food and Drug Administration is about to make changes to drug information — often filled with technical medical jargon — to help consumers understand the risks and benefits of the drugs they take. "University of Florida professor Carole Kimberlin worked with colleagues to sample leaflets from some 400 pharmacies across the country recently at the request of the FDA. They found wide differences. 'Some of them were as little as 30 words, while others were over 2,500 words,' she says.
Case Western Reserve University School of Medicine is honored to announce gifts to establish the inaugural Parker Hannifin - Helen Moss Cancer Research Foundation Professorship in Integrative Oncology. This professorship will establish the School of Medicine and its affiliate hospitals as national leaders in teaching, research, and patient care in the field of integrative oncology.
Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.
Two internationally recognized scientists with strong Philadelphia ties are to receive the John Scott Award this year.
› Verified 4 days ago